Device features for managing patients with heart failure.

[1]  Y. Rudy,et al.  RV electrical activation in heart failure during right, left, and biventricular pacing. , 2010, JACC. Cardiovascular imaging.

[2]  B. Wilkoff,et al.  Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. , 2010, Heart rhythm.

[3]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[4]  B. Kozłowski.  [Commentary to the article: Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-38]. , 2009, Kardiologia polska.

[5]  B. Wilkoff,et al.  Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. , 2009, Journal of the American College of Cardiology.

[6]  S. Hohnloser,et al.  Milestones in the management of atrial fibrillation. , 2009, Heart rhythm.

[7]  N. Varma.  Remote Monitoring for Advisories: Automatic Early Detection of Silent Lead Failure , 2009, Pacing and clinical electrophysiology : PACE.

[8]  D. Panescu,et al.  Ambulatory monitoring of congestive heart failure by multiple bioelectric impedance vectors. , 2009, Journal of the American College of Cardiology.

[9]  P. Kudenchuk,et al.  The DAVID (Dual Chamber and VVI Implantable Defibrillator) II trial. , 2009, Journal of the American College of Cardiology.

[10]  Wilfried Mullens,et al.  Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. , 2009, Journal of the American College of Cardiology.

[11]  N. Varma,et al.  Prevalence of Cancelled Shock Therapy and Relationship to Shock Delivery in Recipients of Implantable Cardioverter‐Defibrillators Assessed by Remote Monitoring , 2009, Pacing and clinical electrophysiology : PACE.

[12]  L. Jordaens,et al.  Analysis of 57,148 Transmissions by Remote Monitoring of Implantable Cardioverter Defibrillators , 2009, Pacing and clinical electrophysiology : PACE.

[13]  W. Wijns,et al.  Chronic monitoring of pulmonary artery pressure in patients with severe heart failure: multicentre experience of the monitoring Pulmonary Artery Pressure by Implantable device Responding to Ultrasonic Signal (PAPIRUS) II study , 2009, Heart.

[14]  S. A. Christman,et al.  Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? , 2009, Journal of the American College of Cardiology.

[15]  G. Hindricks,et al.  Influence of Home Monitoring on the clinical status of heart failure patients: Design and rationale of the IN‐TIME study , 2008, European journal of heart failure.

[16]  D. Mark,et al.  Prognostic importance of defibrillator shocks in patients with heart failure. , 2008, The New England journal of medicine.

[17]  John G F Cleland,et al.  Predicting hospitalization due to worsening heart failure using daily weight measurement: analysis of the Trans‐European Network‐Home‐Care Management System (TEN‐HMS) study , 2008, European journal of heart failure.

[18]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.

[19]  M. Zile,et al.  Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. , 2008, Journal of the American College of Cardiology.

[20]  N. Varma.  Left Ventricular Conduction Delays Induced by Right Ventricular Apical Pacing: Effect of Left Ventricular Dysfunction and Bundle Branch Block , 2008, Journal of cardiovascular electrophysiology.

[21]  K. Furie,et al.  Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.

[22]  William T. Abraham,et al.  Direct Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients: Initial Experience With a New Permanent Implantable Device , 2007, Circulation.

[23]  P. Tchou,et al.  Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. , 2007, The New England journal of medicine.

[24]  Niraj Varma,et al.  Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. , 2007, American heart journal.

[25]  J. Conti,et al.  Reducing Events in Patients with Chronic Heart Failure (REDUCEhf ) Study Design: Continuous Hemodynamic Monitoring with an Implantable Defibrillator , 2007, Clinical cardiology.

[26]  J. Concato,et al.  Patterns of Weight Change Preceding Hospitalization for Heart Failure , 2007, Circulation.

[27]  Christian Butter,et al.  Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. , 2007, European heart journal.

[28]  Jiang Ding,et al.  A Prospective Comparison of AV Delay Programming Methods for Hemodynamic Optimization during Cardiac Resynchronization Therapy , 2007, Journal of cardiovascular electrophysiology.

[29]  I. V. Van Gelder,et al.  Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients. , 2006, Heart rhythm.

[30]  K. Ellenbogen,et al.  The Managed Ventricular Pacing™ Versus VVI 40 Pacing (MVP) Trial: Clinical Background, Rationale, Design, and Implementation , 2006, Journal of cardiovascular electrophysiology.

[31]  P. Kudenchuk,et al.  Abnormal conduction increases risk of adverse outcomes from right ventricular pacing. , 2006, Journal of the American College of Cardiology.

[32]  C. O’loughlin,et al.  Clinical deterioration in established heart failure: What is the value of BNP and weight gain in aiding diagnosis? , 2005, European journal of heart failure.

[33]  E. Antman,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[34]  C. Lau,et al.  Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization , 2005, Circulation.

[35]  D. Kass,et al.  Abnormal conduction and repolarization in late-activated myocardium of dyssynchronously contracting hearts. , 2005, Cardiovascular research.

[36]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[37]  Paul J. Wang,et al.  The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial II , 2005, Journal of cardiovascular electrophysiology.

[38]  William T. Abraham,et al.  Risk stratification for in-hospital mortality in acutely decompensated heart failure. Classification and regression tree analysis , 2005 .

[39]  W John Boscardin,et al.  Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. , 2005, JAMA.

[40]  S. Chun,et al.  Detection of Atrial Fibrillation by Implanted Devices with Wireless Data Transmission Capability , 2005, Pacing and clinical electrophysiology : PACE.

[41]  W. Abraham,et al.  Continuous Autonomic Assessment in Patients With Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device , 2004, Circulation.

[42]  J. Burkhardt,et al.  Remote Interrogation and Monitoring of Implantable Cardioverter Defibrillators , 2004, Journal of Interventional Cardiac Electrophysiology.

[43]  D. Weiss,et al.  Remote Monitoring of Implantable Cardioverter Defibrillators: , 2004, Pacing and clinical electrophysiology : PACE.

[44]  M. Walsh,et al.  Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. , 2003, American heart journal.

[45]  W. Abraham,et al.  Cardiac Resynchronization Therapy Improves Heart Rate Variability in Patients with Symptomatic Heart Failure , 2003, Circulation.

[46]  I. Squire,et al.  Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993–2001 , 2003, Heart.

[47]  David O. Martin,et al.  Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.

[48]  Suneet Mittal,et al.  Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients? , 2002, Journal of the American College of Cardiology.

[49]  Claudia Stöllberger,et al.  Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[50]  T. Bunch,et al.  Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality. , 2009, Heart rhythm.

[51]  A. Waldo.  Is Dual-Chamber Programming Inferior to Single-Chamber Programming in an Implantable Cardioverter-Defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) Study , 2008 .

[52]  L. Tavazzi,et al.  Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). , 2002, American heart journal.